Cancer News and Research

Latest Cancer News and Research

GenomOncology's GO Clinical Workbench selected by UH to launch clinical cancer product

GenomOncology today announced that University Hospitals Case Medical Center and UH Seidman Cancer Center (Cleveland, Ohio) have selected the company's GO Clinical Workbench to launch a clinical cancer product. UH will leverage the GO Clinical Workbench for workflow management from raw sequencing data through delivery of an actionable clinical report for oncologists.

27 Oct 2014

Concord Medical gets approval to establish Datong Meizhong Jiahe Cancer Center

Concord Medical Services Holdings Limited, an operator of specialty cancer hospitals and the largest network of radiotherapy and diagnostic imaging centers in China, today announced that the Company has received relevant government approvals to establish a free-standing radiotherapy cancer center, Datong Meizhong Jiahe Cancer Center ("Datong Center") in Datong City, Shanxi Province.

27 Oct 2014

Understanding of genomic landscape of thyroid cancer

A new comprehensive analysis of thyroid cancer from The Cancer Genome Atlas Research Network has identified markers of aggressive tumors, which could allow for better targeting of appropriate treatments to individual patients.

27 Oct 2014

Bortezomib drug effective against chronic GVHD

Researchers at UC Davis have found that the drug bortezomib effectively treats chronic graft-versus-host disease (GVHD), a common and debilitating side effect from allogeneic hematopoietic stem cell transplants.

27 Oct 2014

Research findings support causal association between LDL-C, aortic valve disease

In an analysis that included approximately 35,000 participants, genetic predisposition to elevated low-density lipoprotein cholesterol (LDL-C) was associated with aortic valve calcium and narrowing of the aortic valve, findings that support a causal association between LDL-C and aortic valve disease, according to a study appearing in JAMA.

27 Oct 2014

RNF43 mutation may serve as biomarker that identifies colorectal, endometrial cancer patients

Scientists say they have identified in about 20 percent of colorectal and endometrial cancers a genetic mutation that had been overlooked in recent large, comprehensive gene searches. With this discovery, the altered gene, called RNF43, now ranks as one of the most common mutations in the two cancer types.

27 Oct 2014

Ludwig researchers discover key mechanism that control plasticity of epithelial cells

Ludwig Oxford researchers have discovered a key mechanism that governs how cells of the epithelia, the soft lining of inner body cavities, shift between a rigid, highly structured and immobile state and a flexible and motile form.

27 Oct 2014

CTI BioPharma acquires worldwide rights to tosedostat

CTI BioPharma Corp. today announced that it has acquired worldwide rights to tosedostat through concurrent transactions with Vernalis R&D Limited, the originator of tosedostat, and Chroma Therapeutics Ltd., through which CTI previously held a sublicense with respect to tosedostat in North, Central and South America.

27 Oct 2014

Salk Institute scientists identify promising target for HIV/AIDS treatment

Like a slumbering dragon, HIV can lay dormant in a person's cells for years, evading medical treatments only to wake up and strike at a later time, quickly replicating itself and destroying the immune system.

27 Oct 2014

Scientists devise novel way to use stem cells in fight against brain cancer

Harvard Stem Cell Institute scientists at Massachusetts General Hospital have devised a new way to use stem cells in the fight against brain cancer. A team led by neuroscientist Khalid Shah, MS, PhD, who recently demonstrated the value of stem cells loaded with cancer-killing herpes viruses, now has a way to genetically engineer stem cells so that they can produce and secrete tumor-killing toxins.

27 Oct 2014

InSilico Medicine, CCARL collaborate to improve personalized medicine projects in multiple sclerosis

InSilico Medicine, the company focused on drug discovery for cancer and age-related diseases, announced its investment in a research collaboration with Canada Cancer and Aging Research Laboratories, Inc. The companies will collaborate on improving decision making in clinical oncology and discovery, and personalized medicine projects in multiple sclerosis (MS).

27 Oct 2014

DOST imaging may help predict tumor response before starting treatment

A Dartmouth study suggests that it may be possible to use Diffuse Optical Spectroscopic Tomographic imaging (DOST) to predict which patients will best respond to chemotherapy used to shrink breast cancer tumors before surgery. These findings could eliminate delays in effective early treatment for tumors unlikely to respond to neoadjuvant chemotherapy (NAC).

27 Oct 2014

Tiny nano-sized particles may play major role in detecting, tracking breast cancer

Exosomes, tiny, virus-sized particles released by cancer cells, can bioengineer micro-RNA (miRNA) molecules resulting in tumor growth. They do so with the help of proteins, such as one named Dicer. New research from The University of Texas MD Anderson Cancer Center suggests Dicer may also serve as a biomarker for breast cancer and possibly open up new avenues for diagnosis and treatment.

27 Oct 2014

New material advances tissue engineering, drug delivery

Researchers at the New York University Polytechnic School of Engineering have broken new ground in the development of proteins that form specialized fibers used in medicine and nanotechnology. For as long as scientists have been able to create new proteins that are capable of self-assembling into fibers, their work has taken place on the nanoscale. For the first time, this achievement has been realized on the microscale—a leap of magnitude in size that presents significant new opportunities for using engineered protein fibers.

27 Oct 2014

Financial burden higher in patients treated for colorectal cancer

Nearly two-thirds of patients treated for colorectal cancer reported some measure of financial burden due to their treatment, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center.

27 Oct 2014

Virginia Tech professor developing vaccine that could help smokers overcome nicotine addiction

A Virginia Tech professor is working on a vaccine that could help smokers conquer their nicotine addiction, making many smoking-related diseases and deaths relics of the 21st century.

27 Oct 2014

UT Southwestern receives CPRIT grant to expand genetic screening services in North Texas

Genetic screening services for rural and underserved populations will expand from six to 22 counties in North Texas under a $1.5 million grant from the Cancer Prevention and Research Institute of Texas to UT Southwestern Medical Center.

26 Oct 2014

UAB offers MRI-US image fusion technique for prostate cancer detection

The latest advancement in prostate cancer detection is magnetic resonance imaging and ultrasound fusion-guided biopsy, which offers benefits for both patient and physician.

25 Oct 2014

Rates of type 1 diabetes increase significantly among non-Hispanic white youth

The rate of non-Hispanic white youth diagnosed with type 1 diabetes increased significantly from 2002 to 2009 in all but the youngest age group of children, according to a new study published today in the journal Diabetes.

25 Oct 2014

Study reveals subtypes, potential diagnostic and treatment clues for papillary thyroid carcinomas

A comprehensive analysis of the genomes of nearly 500 papillary thyroid carcinomas (PTC) – the most common form of thyroid cancer – has provided new insights into the roles of frequently mutated cancer genes and other genomic alterations that drive disease development.

25 Oct 2014

Cancer News and Research

Latest Cancer News and Research

GenomOncology's GO Clinical Workbench selected by UH to launch clinical cancer product

Concord Medical gets approval to establish Datong Meizhong Jiahe Cancer Center

Understanding of genomic landscape of thyroid cancer

Bortezomib drug effective against chronic GVHD

Research findings support causal association between LDL-C, aortic valve disease

RNF43 mutation may serve as biomarker that identifies colorectal, endometrial cancer patients

Ludwig researchers discover key mechanism that control plasticity of epithelial cells

CTI BioPharma acquires worldwide rights to tosedostat

Salk Institute scientists identify promising target for HIV/AIDS treatment

Scientists devise novel way to use stem cells in fight against brain cancer

InSilico Medicine, CCARL collaborate to improve personalized medicine projects in multiple sclerosis

DOST imaging may help predict tumor response before starting treatment

Tiny nano-sized particles may play major role in detecting, tracking breast cancer

New material advances tissue engineering, drug delivery

Financial burden higher in patients treated for colorectal cancer

Virginia Tech professor developing vaccine that could help smokers overcome nicotine addiction

UT Southwestern receives CPRIT grant to expand genetic screening services in North Texas

UAB offers MRI-US image fusion technique for prostate cancer detection

Rates of type 1 diabetes increase significantly among non-Hispanic white youth

Study reveals subtypes, potential diagnostic and treatment clues for papillary thyroid carcinomas

Industry Focus eBook - Immunology (3rd edition) eBook

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Immunology (3rd edition) eBook

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Newsletters you may be interested in